Dr. David Fishman of Ohio Sentenced to Probation in Misbranded Cancer Drug Case

Dr. David Fishman of Euclid, Ohio has been sentenced to probation for his conviction on chargers he illegally imported non-FDA approved cancer medication. Six other Ohio oncologists have been charged in the case. The doctors were charged with a misdemeanor violation of the Food, Drug and Cosmetic Act, the purchasing of misbranded or counterfeit drugs.

Who: Food and Drug Administration Office of Criminal Investigations (FDA_OCI), Department of Health and Human Services – Office of Inspector General., U.S. Department of Justice.

When: November 19, 2013, 2006-2009.

Where:Euclid, Ohio, U.S.A.

How: Investigation by The U.S. Food and Drug Administration Office of Criminal Investigation.

Additional details: Fishman and co-defendant Dr. Hassan Tahsildar, 55 purchased six shipments of oncology drugs Novantron and Taxotere from a Canadian distributor between December 2006 and January 2007. Agents from the FDA went to Fishman’s office in 2009 to tell him the drugs they had purchased from the Canadian distributor were not legal to treat patients and that they should stop administering them.

Related sources:

" Euclid doctor gets probation for importing non-FDA approved cancer medications,"News Herald. November 20, 2013.

" Seven Oncologists Charged With Importing Unapproved Drugs," U.S. Department of Justice Press Release. August 13, 2013.

" August 13, 2013: Seven Oncologists Charged with Importing Unapproved Drugs," FDA Press Release. August 13, 2013.

" NE Ohio doctors accused of importing unapproved drugs,"CantonRep. August 13, 2013.

" Westlake, Parma oncologists charged with importing non-FDA cancer drugs,"WKYC.com. August 13, 2013.

|


Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!

 Email:


2014 Interchange Save the Date

The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
Learn the secrets!


Report Counterfeit and Black Market Medicines

Track & Trace legislation
President Obama signed into law, on November 27, 2013, legislation to enhance the safety of the drug supply chain, which has seen a number of incidents in recent years threaten American patients.   Learn more>>


Get Breaking News

 

Youtube  Follow Us on Twitter Like us on Facebook Flickr Delicious Stumble Upon Tumblr

Drug Safety Alert

Regeneca Worldwide, A Division Of Vivaceuticals, Inc Voluntarily Recalls RegeneSlim Appetite Control Capsules Due To The Presence Of DMAA That May Pose Possible Health Risk (August 8)

counterfeit drug alerts to tweet Tweet this alert!

Counterfeit Drug Incident Encyclopedia

counterfeit drug incident encyclopedia banner